ARCHIVES

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005

Congresswoman Urges Increased Funding For Cancer information Service

August 11, 1989

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

In Brief: No Intention Of Cutting Back On Cancer, Heart Research, Weinberger Spokesman Insists

June 7, 1974

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012